Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure

Published:2023-03-20 Issue:5 Volume:98 Page:326-335
ISSN:1052-0295
Container-title:Biotechnic & Histochemistry
language:en
Short-container-title:Biotechnic & Histochemistry

Author:

Ermis Necip¹^ORCID,Ulutas Zeynep¹^ORCID,Ozhan Onural²^ORCID,Yildiz Azibe³^ORCID,Vardi Nigar³^ORCID,Colak Cemil⁴^ORCID,Parlakpinar Hakan²^ORCID

Affiliation:

1. Department of Cardiology, Faculty of Medicine, Inonu University, Malatya, Turkey

2. Department of Pharmacology, Faculty of Medicine, Inonu University, Malatya, Turkey

3. Department of Histology and Embryology, Faculty of Medicine, Inonu University, Malatya, Turkey

4. Department of Biostatistics and Medical Informatics, Faculty of Medicine, Inonu University, Malatya, Turkey

Funder

There is no funding agency

Publisher

Informa UK Limited

Subject

Medical Laboratory Technology,Histology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10520295.2023.2187461

Reference45 articles.

1. Chronic treatment with apelin, losartan and their combination reduces myocardial infarct size and improves cardiac mechanical function

2. WSSPAS: An Interactive Web Application for Sample Size and Power Analysis with R Using Shiny

3. Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide

4. Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype

5. Role of Type 1 and Type 2 Angiotensin Receptors in Angiotensin II–Induced Cardiomyocyte Hypertrophy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TAOK1-mediated regulation of the YAP/TEAD pathway as a potential therapeutic target in heart failure;PLOS ONE;2024-08-09

2. Echinacoside ameliorates doxorubicin‑induced cardiac injury by regulating GPX4 inhibition‑induced ferroptosis;Experimental and Therapeutic Medicine;2023-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3